Early experience with chemotherapy intensification for poor-prognosis metastatic germ cell cancer and unfavorable tumor marker decline

机译：化疗强化治疗转移性生殖细胞癌预后不良和肿瘤标志物下降不利的早期经验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Intensified chemotherapy improved outcomes for men with poor-prognosis metastatic germ cell cancer (GCC) and unfavorable tumor marker decline after one cycle of bleomycin, etoposide, and cisplatin (BEP) chemotherapy in the GETUG-13 trial. Herein, we report our experience to date using a similar approach.

机译：GETUG-13试验的一个周期的博来霉素，依托泊苷和顺铂（BEP）化疗一疗程后，强化化疗改善了预后差的转移性生殖细胞癌（GCC）和肿瘤标志物下降不利的男性的预后。在此，我们使用类似的方法报告迄今为止的经验。

著录项

期刊名称 Canadian Urological Association Journal
作者
Anupam Batra; Scott Ernst; Kylea Potvin; Ricardo Fernandes; Nicholas Power; James Vanhie; Eric Winquist;
展开▼
作者单位

展开▼
年(卷),期 2020(14),2
年度 2020
页码 -1
总页数 5
原文格式 PDF
正文语种
中图分类泌尿科学（泌尿生殖系疾病）;小儿泌尿科学;肾疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Early experience with chemotherapy intensification for poor-prognosis metastatic germ cell cancer and unfavorable tumor marker decline [J] . Anupam Batra, Scott Ernst, Kylea Potvin, Canadian Urological Association Journal . 2020,第2期

机译：早期经验，化疗增强对贫病预后转移性毒细胞癌和不利的肿瘤标志物下降
2. BOMP/EPI intensive alternating chemotherapy for IGCCC poor-prognosis germ-cell tumors: the Spanish Germ-Cell Cancer Group experience (GG) (see comments) [J] . Germa Lluch-JR, Garcia del-Muro-X, Tabernero JM, Annals of oncology: official journal of the European Society for Medical Oncology . 1999,第3期

机译：IGCCC预后不良的生殖细胞肿瘤的BOMP / EPI强化交替化疗：西班牙生殖细胞癌研究组的经验（GG）（请参阅评论）
3. Chemotherapy intensification for first-line treatment of poor-prognosis metastatic germ cell cancer is not yet ready for prime time [J] . Di Maria Jiang, Robert J. Hamilton, Aaron R. Hansen Canadian Urological Association Journal . 2020,第2期

机译：化疗强化贫困预后转移性毒性细胞癌的一线治疗尚未准备好粉末时间
4. Is Early Chemotherapy Switch the Standard Treatment for Poor-Risk Metastatic Germ Cell Tumor Metastatic Disease and Slow Tumor Marker Decline? [C] . Christopher J. Sweeney Genitourinary Cancers Symposium. . 2014

机译：是早期化疗切换标准治疗差风险的转移性毒细胞肿瘤转移性疾病和缓慢肿瘤标志物下降吗？
5. Toll-like receptor (TLR) expression and function of immune system cells from metastatic breast cancer patients with circulating tumor cells. [D] . Green, Taryn Lindsey. 2013

机译：Toll样受体（TLR）的表达和具有循环肿瘤细胞的转移性乳腺癌患者免疫系统细胞的功能。
6. Chemotherapy intensification for first-line treatment of poor-prognosis metastatic germ cell cancer is not yet ready for prime time [O] . Di Maria Jiang, Robert J. Hamilton, Aaron R. Hansen 2020

机译：一线治疗预后不良的转移性生殖细胞癌的化学疗法增强尚无准备
7. Chemotherapy intensification for first-line treatment of poor-prognosis metastatic germ cell cancer is not yet ready for prime time [O] . Di Maria Jiang, Robert J. Hamilton, Aaron R. Hansen 2020

机译：化疗强化贫困预后转移性毒性细胞癌的一线治疗尚未准备好粉末时间

Early experience with chemotherapy intensification for poor-prognosis metastatic germ cell cancer and unfavorable tumor marker decline

摘要

著录项

相似文献

相关主题

期刊订阅